RWMG
CLRB icon

Redwood Wealth Management Group’s Cellectar Biosciences CLRB Stock Holding History

Redwood Wealth Management Group’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed -$2.5K – 339
2024
Q2 		$2.5K Buy
+33
New +$3.17K ﹤0.01% 866

Other funds holding CLRB

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redwood Wealth Management Group's CLRB Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Cellectar Biosciences (CLRB) in Q3 2024, closing a stake of 33 shares — an estimated $2.5K sold.

Redwood Wealth Management Group first reported a position in CLRB in Q2 2024 and held it in 1 quarter. The position peaked at $2.5K in Q2 2024. 35 funds tracked by Wall St. Rank hold CLRB as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Cellectar Biosciences position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 33 Cellectar Biosciences shares in Q3 2024, an estimated $2.5K.
  • Redwood Wealth Management Group first reported a position in Cellectar Biosciences in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's Cellectar Biosciences position peaked at $2.5K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.